IURTC works hard to make the technology commercialization process easy for IU faculty and researchers. Learn more about the people who have worked with IURTC and how their discoveries are improving lives, fueling innovation, and bringing new economic development to Indiana.
Professor Michael Kubek discovered an innovative method for delivering medication to the brain. IURTC helped him patent his discovery and secure additional research investment from Citizens United for Research in Epilepsy (CURE).
Professor Ali Jafari and student David Mills approached IURTC in 2000 for help starting up ANGEL Learning. In 2009, their company sold to Blackboard, Inc., for $100 million.
Professor Ann Elsner and her team developed a low-cost diagnostic camera that can help diagnose diabetic retinopathy, which leads to vision loss and blindness, at the earliest stages, when treatment is still possible. IURTC helped them with the patent process.
The laboratory of Professor Richard DiMarchi is exploring new therapeutics for treatment of diabetes and obesity. In 2010, Marcadia Biotech, founded by Professor DiMarchi, was acquired by Roche. Separately, the DiMarchi laboratory is investigating new insulin analogs that have been licensed to Merck by IURTC and a unique glucagon analog sublicensed by Marcadia to Lilly.
Professors David S. Wilkes and Michael Klemsz started ImmuneWorks to develop a new treatment that may help improve the success rate of lung transplant surgery.
Professor Theordore Widlanski works to promote the importance of economic development among Indiana University Faculty.